Marinos C. Dalakas
Expertise in
16
conditions

Dr. Marinos C. Dalakas

Neurology | Neuromusculoskeletal Medicine
Jefferson University Physicians
900 Walnut St 2nd Floor, Jeff Hosp For Neuro, 
Philadelphia, PA 
Offers Telehealth
Expertise in
16
conditions
Jefferson University Physicians
900 Walnut St 2nd Floor, Jeff Hosp For Neuro, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Marinos Dalakas, MD is a Neurology Specialist in Philadelphia, PA and has over 50 years of experience in the medical field. He graduated from University Of Athens, School Of Health Sciences in 1972. He is affiliated with medical facilities Thomas Jefferson University Hospital and Jefferson Methodist Hospital.

Dr. Dalakas is highly rated in 16 conditions, according to our data. Their top areas of expertise are Stiff Person Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Hereditary Hyperekplexia, Chronic Polyradiculoneuritis, and Laminectomy.

Their clinical research consists of co-authoring 250 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
UMDNJ - NJ University of Medicine and Dentistry
Specialties
Neurology
Neuromusculoskeletal Medicine
Licenses
Psychiatry & Neurology in PA
Board Certifications
Neurology
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

JEFFERSON UNIVERSITY PHYSICIANS
900 Walnut St 2nd Floor, Jeff Hosp For Neuro, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
Oral CLADribine in Patients That Change From First-line Disease Modifying Treatments for Multiple Sclerosis: a pROspective effectivenesS and Safety Study (CLAD CROSS)
Oral CLADribine in Patients That Change From First-line Disease Modifying Treatments for Multiple Sclerosis: a pROspective effectivenesS and Safety Study (CLAD CROSS)
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-Polio Syndrome
A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-Polio Syndrome
Enrollment Status: Terminated
Publish Date: November 27, 2023
Intervention Type: Drug, Biological
Study Drug: Flebogamma
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

250 Total Publications

Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and KLK10-Gene Variants.
Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and KLK10-Gene Variants.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 11, 2025
Similar Doctors
Expertise in
46
conditions
Dr. Lauren B. Elman
Neurology
Expertise in
46
conditions
Dr. Lauren B. Elman
Neurology

University Of Penn-Medical Group

330 S 9th St, 
Philadelphia, PA 
 (0.5 mi)
Languages Spoken:
English
See accepted insurances

Lauren Elman is a Neurologist in Philadelphia, Pennsylvania. Dr. Elman is highly rated in 46 conditions, according to our data. Her top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Myotonic Dystrophy Type 2, and Myotonic Dystrophy.

Expertise in
16
conditions
Dr. David A. Wolk
Neurology
Expertise in
16
conditions
Dr. David A. Wolk
Neurology

University Of Penn-Medical Group

3400 Civic Ctr Blvd, 
Philadelphia, PA 
 (1.8 mi)
215-662-3487
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Wolk is a Neurologist in Philadelphia, Pennsylvania. Dr. Wolk is highly rated in 16 conditions, according to our data. His top areas of expertise are Dementia, Alzheimer's Disease, Frontotemporal Dementia, Memory Loss, and Deep Brain Stimulation.

Expertise in
24
conditions
Dr. Goran Rakocevic
Neurology
Expertise in
24
conditions
Dr. Goran Rakocevic
Neurology

Jefferson University Physicians

909 Walnut St, 
Philadelphia, PA 
 (0.3 mi)
215-955-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Goran Rakocevic is a Neurologist in Philadelphia, Pennsylvania. Dr. Rakocevic is highly rated in 24 conditions, according to our data. His top areas of expertise are Stiff Person Syndrome, Inclusion Body Myositis, Hereditary Hyperekplexia, and Myasthenia Gravis. Dr. Rakocevic is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dalakas's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 33 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile